BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2892114)

  • 1. Regulation of hepatic glucose output by glucose in vivo.
    Müller MJ; Möring J; Seitz HJ
    Metabolism; 1988 Jan; 37(1):55-60. PubMed ID: 2892114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of difference in glucose infusion rate on quantification of hepatic glucose production.
    Sheu WH; Hollenbeck CB; Wu MS; Jaspan JB; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1990 May; 70(5):1354-60. PubMed ID: 1970829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Jennings AS; Keller U; Lacy WW
    J Clin Invest; 1976 Dec; 58(6):1407-18. PubMed ID: 993351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
    Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucoregulatory function of glucagon in hypo-, eu- and hyperthyroid miniature pigs.
    Müller MJ; Mitchinson PE; Paschen U; Seitz HJ
    Diabetologia; 1988 Jun; 31(6):368-74. PubMed ID: 2901376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
    Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
    Meneilly GS; Minaker KL; Elahi D; Rowe JW
    Metabolism; 1988 Mar; 37(3):252-6. PubMed ID: 2893970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
    Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
    J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.
    Altszuler N; Gottlieb B; Hampshire J
    Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of net hepatic substrate balance by phenacylimidazolium ions in the conscious dog.
    Pagliassotti MJ; Colburn CA; Moore MC; Neal DW; Dominianni SJ; Stephens TW; Cherrington AD
    Diabetes Res; 1993; 22(3):123-33. PubMed ID: 7915646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
    Dardevet D; Moore MC; Neal D; DiCostanzo CA; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon and glucose tolerance in liver cirrhosis.
    Greco AV; Altomonte L; Ghirlanda G; D'Anna LM; Manna R; Caputo S; Uccioli L
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):337-45. PubMed ID: 2899368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver.
    Keller U; Sonnenberg GE; Burckhardt D; Perruchoud A
    J Clin Endocrinol Metab; 1982 May; 54(5):961-8. PubMed ID: 6120952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
    Efendic S; Karlander S; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1953-61. PubMed ID: 3290257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fructose on hepatic glucose metabolism in humans.
    Dirlewanger M; Schneiter P; Jéquier E; Tappy L
    Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E907-11. PubMed ID: 11001775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.